Darupakhsh Pharmaceutical Chemistry Company (DSHIMI) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DSHIMI
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 8,665,883 | 6,442,028 | 4,920,196 | 7,478,193 | 2,660,078 | 2,187,051 |
| Cost of operating revenue | -5,172,210 | -4,305,148 | -3,583,322 | -4,774,672 | -1,233,793 | -1,028,528 |
| Gross profit (loss) | 3,493,673 | 2,136,880 | 1,336,874 | 2,703,521 | 1,426,285 | 1,158,523 |
| Selling, general and administrative expenses | -371,733 | -261,238 | -255,867 | -136,197 | -109,925 | -82,628 |
| Other income | 129,389 | 84,367 | 2,469 | 26,222 | 5,667 | 28,849 |
| Other expenses | -383,374 | -230,938 | -342,259 | -70 | 0 | -10,476 |
| Operating profit (loss) | 2,867,955 | 1,729,071 | 741,217 | 2,593,476 | 1,322,027 | 1,094,268 |
| Finance costs | -579,572 | -367,867 | -154,606 | -243,686 | -162,382 | -95,101 |
| Other non-operating income and expenses | 6,263 | 6,086 | 45,801 | 82,927 | 8,133 | -31,102 |
| Profit (loss) from continuing operations before tax | 2,294,646 | 1,367,290 | 632,412 | 2,432,717 | 1,167,778 | 968,065 |
| Current year tax | -474,872 | -238,039 | -134,099 | -282,104 | -262,729 | -216,904 |
| Net profit (loss) from continuing operations | 1,819,774 | 1,129,251 | 498,313 | 2,150,613 | 905,049 | 751,161 |
| Net profit (loss) | 1,819,774 | 1,129,251 | 498,313 | 2,150,613 | 905,049 | 751,161 |
| Basic earnings (loss) per share | 2,033 rials | 1,255 rials | 553 rials | 2,790 rials | 1,989 rials | 2,946 rials |
| Net earnings (loss) per share, rials | 2,022 rials | 1,255 rials | 554 rials | 2,390 rials | 1,990 rials | 1,651 rials |
| Capital | 900,000 | 900,000 | 900,000 | 900,000 | 455,000 | 455,000 |
Reporting periods
83 periods are on file for this report, from the period ending 1387/12/30 to the period ending 1405/06/31.